Download PDF
1 / Pages

Other users also viewed these articles

Clinical Advantage of Attaining Index-Based Remission Prior to Composite Remission in Treating Rheumatoid Arthritis Ichiro Yoshii; Tatsumi Chijiwa; Naoya Sawada;
Reumatol Clin. 2022;18:574-9
Effectiveness and safety of tocilizumab in monotherapy in biologic-naïve and non-naïve patients with rheumatoid arthritis in a real-world setting Sara Marsal Barril; Mª Auxiliadora Martin-Martinez; Francisco Javier Blanco-Garcia; Antonio Fernández-Nebro; Rosario García de Vicuña; Jesús Tornero-Molina; Fernando Sánchez-Alonso; Marta Novella-Navarro; Alejandro Escudero-Contreras; Juan José Alegre-Sancho; Ana Urruticoechea-Arana; Maria Sagrario Bustabad-Reyes; Pilar Trenor-Larraz; Trinidad Pérez-Sandoval; Maria Isabel Tevar-Sánchez; Jesús T. Sánchez-Costa; Enrique Raya-Álvarez;
Reumatol Clin. 2022;18:567-73
Prognostic factors for sustained remission in a ¿Real Life¿ cohort of rheumatoid arthritis patients Ángeles Acosta-Mérida; Antonio Naranjo; Carlos Rodríguez-Lozano;
Reumatol Clin. 2020;16P2:405-9